Basic data and treatment outcome for group A and group B
| Group A – sclerosing injections | Group B – arthroscopy | ||
|---|---|---|---|
| Variable | Mean (SD) | Mean (SD) | Significance (p value) |
| Age, years | 27.0 (7.6) | 26.6 (7.6) | 0.755 |
| Duration of symptoms, months | 20.0 (10.4) | 23.8 (15.5) | 0.596 |
| VAS at rest at assessment | 37.8 (24.9) | 44.6 (28.4) | 0.431 |
| VAS at activity at assessment | 69.0 (17.3) | 76.5 (13.6) | 0.143 |
| Follow-up time, months | 13.7 (6.9) | 12.9 (7.8) | 0.719 |
| VAS at rest at follow-up | 19.2 (23.2) | 5.0 (8.3) | 0.004 |
| VAS at activity at follow-up | 41.1 (28.5) | 12.8 (19.3) | 0.001 |
| Satisfaction with result, 0–100 | 52.9 (32.6) | 86.8 (20.8) | 0.000 |
VAS, visual analogue scale.